COMETE-19: Covid-19 at the Regional Medical Center Metz-Thionville: a Descriptive Study

Sponsor

Centre Hospitalier Régional Metz-Thionville (Other)

Overall Status

Recruiting

CT.gov ID

NCT04430322

Collaborator

(none)

330

Enrollment

Location

Anticipated Duration (Months)

11.8

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

France and especially the region "Grand Est" have been damaged by the COVID-19 pandemic. This pandemic resulted in a reorganization of the hospitalization sectors.

In order to better understand the disease, the investigators wish to carry out a descriptive analysis of hospitalized patient data. This study would notably allow us to identify some prognostic factors.

The main objective of this study is to identify individual factors that are associated with a poor prognosis (with ICU admission or death).

Condition or Disease	Intervention/Treatment	Phase
COVID

Study Design

Study Type:

Observational

Anticipated Enrollment :

330 participants

Observational Model:

Other

Time Perspective:

Retrospective

Official Title:

Coronavirus Disease 2019 (Covid-19) at the Regional Hospital Center Metz-Thionville: a Descriptive Study

Actual Study Start Date :

Mar 1, 2020

Actual Primary Completion Date :

Jun 30, 2021

Anticipated Study Completion Date :

Jun 30, 2022

Outcome Measures

Primary Outcome Measures

ICU admission [Day 1]
Number of ICU admission during the hospitalization

Secondary Outcome Measures

Hospitalization [Day 1]
The duration of the hospitalization
Length of stay at the ICU [Day 1]
The duration of stay at the ICU
Death [Day 1]
The occurrence of death during the stay
CT scan result [Day 1]
Evocative CT scan result
C reactive protein [Day 1]
C reactive protein value
Blood Count [Day 1]
Blood Count value
Sodium [Day 1]
Sodium value
Urea [Day 1]
Urea value
Troponine [Day 1]
Troponine value via biological data
Liver function [Day 1]
Transaminases value
Coagulation test [Day 1]
Quick test result
Creatinine [day 1]
creatinine value
Clearance [day 1]
creatinine clearance value
Potassium [day 1]
potassium value
Calcium [day 1]
calcium value
Gamma-glutamyl transpeptidase [day 1]
Gamma-glutamyl transpeptidase value
Bilirubine [day 1]
Bilirubine value
Alcaline phosphatase [Day 1]
Alcaline phosphatase value
Prothrombine [Day 1]
Prothrombine value

Eligibility Criteria

Criteria

Ages Eligible for Study:

N/A and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Patient hospitalized in COVID Unit at the Regional Hospital Center Metz-Thionville during the COVID 19 pandemic
PCR positive or COVID confirmed with clinical evidence and CT scan

Exclusion Criteria:

Patients not willing to participate via using their medical files
Patient transferred after a brief stay in another hospital

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	CHR Metz Thionville	Metz		France	57085

Sponsors and Collaborators

Centre Hospitalier Régional Metz-Thionville

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Centre Hospitalier Régional Metz-Thionville

ClinicalTrials.gov Identifier:

NCT04430322

Other Study ID Numbers:

2020-02Obs-CHRMT

First Posted:

Jun 12, 2020

Last Update Posted:

Jul 30, 2021

Last Verified:

Jul 1, 2021

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Study Results

No Results Posted as of Jul 30, 2021